SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 98 filers reported holding SAGENT PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $9,518,000 | +9.9% | 635,396 | -10.8% | 0.00% | 0.0% |
| Q1 2016 | $8,664,000 | +104.2% | 711,940 | +167.0% | 0.00% | +200.0% |
| Q4 2015 | $4,243,000 | +12.0% | 266,693 | +8.0% | 0.00% | 0.0% |
| Q3 2015 | $3,787,000 | -28.5% | 247,036 | +13.4% | 0.00% | 0.0% |
| Q2 2015 | $5,296,000 | +8.9% | 217,861 | +4.2% | 0.00% | 0.0% |
| Q1 2015 | $4,863,000 | -4.4% | 209,145 | +3.3% | 0.00% | 0.0% |
| Q4 2014 | $5,085,000 | -31.3% | 202,517 | -14.9% | 0.00% | -50.0% |
| Q3 2014 | $7,400,000 | -41.0% | 237,931 | -51.0% | 0.00% | 0.0% |
| Q2 2014 | $12,546,000 | +272.0% | 485,148 | +236.1% | 0.00% | +100.0% |
| Q1 2014 | $3,373,000 | -3.3% | 144,331 | +5.0% | 0.00% | 0.0% |
| Q4 2013 | $3,489,000 | -16.6% | 137,462 | -33.0% | 0.00% | 0.0% |
| Q3 2013 | $4,184,000 | +99.0% | 205,146 | +104.7% | 0.00% | 0.0% |
| Q2 2013 | $2,103,000 | – | 100,205 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 453,392 | $11,022,000 | 1.89% |
| GREAT POINT PARTNERS LLC | 141,900 | $3,450,000 | 1.34% |
| Penn Capital Management Company, LLC | 1,247,428 | $30,325,000 | 1.25% |
| Ranger Investment Management | 982,240 | $23,878,000 | 1.16% |
| HealthCor Management, L.P. | 912,381 | $22,180,000 | 1.12% |
| Piermont Capital Management Inc. | 138,380 | $3,364,000 | 1.02% |
| JW Asset Management, LLC | 111,630 | $2,714,000 | 0.82% |
| SECTORAL ASSET MANAGEMENT INC | 465,625 | $11,319,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 28,000 | $681,000 | 0.42% |
| Tekla Capital Management LLC | 409,500 | $9,955,000 | 0.36% |